Adamantia Bratsiakou

Dr. Adamantia Bratsiakou

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2024 in American Journal of Hypertension
Verified
Journal Article
Closed access
PDF file
ABAdamantia Bratsiakou
Adamantia Bratsiakou
MTMarieta Theodorakopoulou
Marieta Theodorakopoulou
FIFotini Iatridi
Fotini Iatridi
PSPantelis Sarafidis
Pantelis Sarafidis
CDChristos Davoulos
Christos Davoulos
MPMarios Papasotiriou
Marios Papasotiriou
BACKGROUND: Increased aortic blood pressure (BP) and arterial stiffness are associated with higher cardiovascular risk in hemodialysis. Previous works showed that lower dialysate sodium is associated with lower brachial-BP; data on aortic-BP and arterial stiffness are limited. This study aimed to investigate the effects of different dialysate sodium concentrations on 72-hour aortic-BP and arterial stiffness parameters in hemodialysis patients. METHODS: This analysis is part of a prospective, non-randomized interventional study. Twenty-five hemodialysis patients underwent a set of 3 periods of different dialysate sodium concentrations; 6 sessions with dialysate sodium of 137 mEq/l, followed consecutively by 6 sessions with 139 mEq/l and, finally, 6 sessions with 141 mEq/l. At the start of the sixth hemodialysis session on each sodium concentration, 72-hour ABPM (Mobil-O-Graph) was performed to evaluate aortic-BP and arterial stiffness indices during the overall 72-hour, different 24-hour, daytime, and nighttime periods. RESULTS: Mean 72-hour aortic systolic blood pressure (SBP)/diastolic blood pressure (DBP) were higher with increasing dialysate sodium concentrations (137 mEq/l: 114.2 ± 15.3/77.0 ± 11.8 mm Hg vs. 139 mEq/l: 115.4 ± 17.3/77.9 ± 14.0 mm Hg vs. 141 mEq/l: 120.5 ± 18.4/80.5 ± 14.7 mm Hg, P = 0.002/P = 0.057, respectively). Wave-reflection parameters (AIx, AIx(75), AP) were not significantly different between the 3 dialysate sodium concentrations. Ambulatory pulse wave velocity (PWV) was significantly higher with increasing dialysate sodium concentrations (137 mEq/l: 8.5 ± 1.7 m/s vs. 139 mEq/l: 8.6 ± 1.6 m/s vs. 141 mEq/l: 8.8 ± 1.6 m/s, P < 0.001). In generalized linear mixed models including 72-hour brachial SBP as a random covariate, the adjusted marginal means of 72-hour PWV were not significantly different between groups. CONCLUSIONS: This study showed that higher dialysate sodium concentrations are associated with significant increases in ambulatory aortic BP and PWV. These findings further support the need for modification of dialysate sodium concentration in hemodialysis.

2 December 2024 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
MGMercedes Gori
Mercedes Gori
DADomenico Abelardo
Domenico Abelardo
APAnnalisa Pitino
Annalisa Pitino
ESEleni Stamellou
Eleni Stamellou
ABAdamantia Bratsiakou
Adamantia Bratsiakou
GDGraziella D'Arrigo
Graziella D'Arrigo

Verified
Journal Article
Open access
PDF file
ABAdamantia Bratsiakou
Adamantia Bratsiakou
MPMarios Papasotiriou
Marios Papasotiriou
PDPanagiota Davoulou
Panagiota Davoulou
GGGeorgia Andriana Georgopoulou
Georgia Andriana Georgopoulou
EPEvangelos Papachristou
Evangelos Papachristou
DGDimitrios S. Goumenos
Dimitrios S. Goumenos
Patients on standard hemodialysis (HD) show insufficient clearance of medium-molecular-weight uremic toxins, resulting in long-term complications. In this study we investigated the effectiveness of expanded HD (xHD) in the clearance of medium-molecular-weight uremic substances. This prospective study included patients on standard thrice-weekly HD. Participants were treated with xHD for 4 weeks, and the clearance of urea and β2-microglobulin was measured at the beginning and at the end of the study and compared with standard HD (sHD). Moreover, we investigated the clearance of Su-PAR, MCP-1, and activin, comparing sHD, xHD, and online hemodiafiltration (HDF). xHD had the same efficiency in the removal of low-molecular-weight substances compared to sHD but led to a significant decrease in β2-microglobulin levels from the first application of the method (sHD: from 36.9 ± 10.6 to 39.7 ± 18.9 mg/dL, p = 0.595 vs. 1st xHD: from 40 (36.5, 41.8) to 11 (9.8, 13.2) mg/dL, p = 0.008 vs. after 4 weeks on xHD: from 31.5 (28.5, 34.5) to 8.7 (8.2, 9.0) mg/dL, p = 0.008). Moreover, pre-session β2-microglobulin levels significantly decreased after 4 weeks on xHD. Su-PAR, MCP-1, and activin during xHD were also significantly reduced. xHD leads to a significant and cumulative reduction in medium-molecular-weight uremic toxins compared to standard HD.

11 October 2024 in American Journal of Hypertension
Verified
Journal Article
Open access
PDF file
ABAdamantia Bratsiakou
Adamantia Bratsiakou
FIFotini Iatridi
Fotini Iatridi
EPEvangelos Papachristou
Evangelos Papachristou
MPMarios Papasotiriou
Marios Papasotiriou
To the Editor: Response to “Dialysate Sodium, PWV, and Clinical Outcomes: The Missing Link of Sodium Stores and the Need for Rigorous Trials”. We thank Dr Sahutoglu for his interest in our manuscript and we appreciate the opportunity to reply to his concerns regarding mainly our results on pulse wave velocity (PWV).1

13 June 2025 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
FMFrancesca Mallamaci
Francesca Mallamaci
ABAdamantia Bratsiakou
Adamantia Bratsiakou
GDGraziella D'Arrigo
Graziella D'Arrigo
GTGiovanni Tripepi
Giovanni Tripepi
Nicola LambertiNicola Lamberti
Nicola Lamberti
carmine zoccalicarmine zoccali
carmine zoccali
Key Points: Inactivity in patients with ESKD worsens quality of life, function, and increases morbidity. Post hoc analysis of the EXerCise Introduction to Enhance Performance in Dialysis trial explores 6-month exercise effects in dialysis patients, stratified by sex. Sex-based findings may inform tailored interventions to enhance function and quality of life in patients with ESKD. Background: Physical inactivity in patients with ESKD is linked to poor quality of life, lower physical function, and higher morbidity. Promoting physical activity and improving performance is vital for their care. This post hoc analysis of the EXerCise Introduction to Enhance Performance in Dialysis trial examined the effects of a 6-month exercise program for dialysis patients stratified by sex. Methods: In the EXerCise Introduction to Enhance Performance in Dialysis trial participants were randomized into an exercise versus a control group. Eligible patients were recruited from 13 centers over November 2009–February 2011 and were followed for 36 months. This analysis focused on sex-stratified effects, including 227 dialysis patients (151 men, 76 women) who completed the 6-minute walking distance (6MWD) test and the five times sit-to-stand (5STS) test at baseline and after 6 months. The primary outcomes were changes in 6MWD and 5STS over a 6-month period. Data were analyzed using linear regression models to assess sex as an effect modifier. Results: Both male (+37.1 versus +12.6 m, P = 0.005) and female (+42.7 versus −18.5 m, P < 0.001) patients in the exercise group showed significant improvements in 6MWD compared with controls. In unadjusted (P = 0.02) and fully adjusted (P = 0.006) interaction analyses, the response to this test in women improved more than in men. In sex-stratified analyses, the between-group difference in the response to the 5STS was numerically larger in women (−2.5 versus +0.4 seconds, P = 0.007) than in men (−2.4 versus −1.2 seconds, P = 0.06), but this difference did not reach statistical significance in interaction analysis (unadjusted, P = 0.15; fully adjusted, P = 0.11). Conclusions: The exercise program improved physical performance in dialysis patients, with women showing more significant enhancements in 6MWD. These exploratory findings suggest that sex-specific physiologic differences may influence exercise outcomes in dialysis patients. Clinical Trial registry name and registration number: NCT01255969.

12 November 2026 in Journal Of Nephrology
Verified
Journal Article
Open access
TPThemistoklis Paraskevas
Themistoklis Paraskevas
ABAdamantia Bratsiakou
Adamantia Bratsiakou
PPPanagiota Perdiki
Panagiota Perdiki
DCDionysios Chartoumpekis
Dionysios Chartoumpekis
EPEvangelos Papachristou
Evangelos Papachristou
MPMarios Papasotiriou
Marios Papasotiriou
Background: Frailty is a common condition among older adults with high prevalence within the dialysis population, but there has not been a large-scale investigation among European older adults with reduced eGFR. The objectives of this study are to describe the proportion of frailty among adults aged ≥50 years with reduced eGFR in the Survey of Health, Ageing and Retirement in Europe (SHARE) and assess the association between frailty, eGFR, and patient-reported outcomes. Methods: We used cross-sectional data from Wave 6 of SHARE. Participants were categorized using CKD-EPI 2012 cystatin-based equations. Frailty was measured with the Fried’s Frailty Scale. Results: A total of 23,028 participants with a mean age of 68 years were included in the analysis. The proportion of pre-frailty/frailty was higher in the lower eGFR categories: 49% of those with eGFR≥60 ml/min/1.73m2, 75.0% of those with eGFR:45-59 ml/min/1.73m2 (G3a), 87.3% of eGFR:30-44 ml/min/1.73m2 (G3b), and 92.9% of eGFR≤29 ml/min/1.73m2 (G4/G5) were classified as pre-frail or frail. GFR categories were associated with frailty categories after adjustment for age and sex. Compared to subjects with eGFR≥60 ml/min/1.73m2, those in the G3a, G3b, and G4/G5 categories had 1.18, 1.28 and 2.11 times higher odds for worse self-rated health, respectively. Quality of life scores were lower in participants with reduced eGFR, while impairments in instrumental activities of daily living were more common. Conclusions: Increased frailty levels are common in adults with reduced eGFR. Lower eGFR categories were consistently associated with frailty and greater IADL impairment. Geriatric assessments should be considered in this population.